Impact of HPV vaccination with Gardasil® in Switzerland

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 6 January 2018)

Research article
Impact of HPV vaccination with Gardasil® in Switzerland
Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomaviruses (HPV), has been offered to 11–14 year-old schoolgirls in Switzerland since 2008. To evaluate its succe…
Authors: Martine Jacot-Guillarmod, Jérôme Pasquier, Gilbert Greub, Massimo Bongiovanni, Chahin Achtari and Roland Sahli
Citation: BMC Infectious Diseases 2017 17:790
Published on: 22 December 2017